Sera from patients with Clostridium difficile-associated disease (CDAD) and sera from a control group were analysed by an ELISA to detect antibodies directed against four surface proteins and toxins A and B of C. difficile. The surface proteins were the flagellar cap protein FliD, the flagellin FliC, the adhesin Cwp66 divided into two domains, Cwp66-Nterminal and Cwp66-Cterminal, and the fibronectin-binding protein Fbp68. For each antigen, antibody levels in the CDAD patient group and in the control group were compared. In the CDAD patient group, the mean of the antibody levels decreased from Cwp66-Cterminal to Fbp68, FliD, toxins B and A, Cwp66-Nterminal and finally FliC, suggesting different immunogenic properties among these adhesins. For Cwp66-Nterminal, FliC, FliD and Fbp68, the antibody level observed in the control group was higher than in the CDAD group with a statistically significant difference whereas the antibody level for toxins A and B was not statistically different. In conclusion, this study suggests that during the clinical course of disease, C. difficile adhesins are able to induce an immune response which could play a role in the defence mechanism of the host.
HennequinC.,
JanoirC.,
BarcM.-C.,
CollignonA.,
KarjalainenT.2003; Identification and characterization of a fibronectin-binding protein from Clostridium difficile
. Microbiology 149:2779–2787[CrossRef]
KyneL.,
WarnyM.,
QamarA.,
KellyC. P.2000; Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342:390–397[CrossRef]
MaheS.,
CorthierG.,
DubosF.1987; Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice. Infect Immun 55:1801–1805
McFarlandL. V.,
MulliganM. E.,
KwokR. Y. Y.,
StammW. E.1989; Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320:204–210[CrossRef]
MulliganM. E.,
MillerS. D.,
McFarlandL. V.,
FungH. C.,
KwokR. Y. Y.1993; Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile
. Clin Infect Dis 16:S239–S244[CrossRef]
RupnikM.,
AvesaniV.,
JancM.,
Von Eichel-StreiberC.,
DelméeM.1998; A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247
TasteyreA.,
KarjalainenT.,
AvesaniV.,
DelméeM.,
CollignonA.,
BourliouxP.,
BarcM.-C.2000b; Phenotypic and genotypic diversity of the flagellin gene ( fliC ) among Clostridium difficile isolates from different serogroups. J Clin Microbiol 38:3179–3186
TasteyreA.,
BarcM.-C.,
CollignonA.,
KarjalainenT.2001a; Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun 69:7937–7940[CrossRef]
TasteyreA.,
KarjalainenT.,
AvesaniV.,
DelméeM.,
CollignonA.,
BourliouxP.,
BarcM.-C.2001b; Molecular characterization of fliD gene encoding flagellar cap and its expression among Clostridium difficile isolates from different serogroups. J Clin Microbiol 39:1178–1183[CrossRef]
ViscidiR.,
LaughonB. E.,
YolkenR.,
Bo-LinnP.,
MoenchT.,
RyderR. W.,
BartlettJ. G.1983; Serum antibody response to toxins A and B of Clostridium difficile
. J Infect Dis 148:93–100[CrossRef]
WaligoraA.-J.,
HennequinC.,
MullanyP.,
BourliouxP.,
CollignonA.,
KarjalainenT.2001; Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun 69:2144–2153[CrossRef]
WarnyM.,
VaermanJ.-P.,
AvesaniV.,
DelméeM.1994; Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 62:384–389
WinstanleyC.,
MorganJ. A.1997; The bacterial flagellin gene as a biomarker for detection, population genetics and epidemiological analysis. Microbiology 143:3071–3084[CrossRef]